| P2093 | author name string | Gilbert DN | |
| P2860 | cites work | Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? | Q28329301 |
| | Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs | Q28332516 |
| | Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity | Q69496341 |
| | A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections | Q69522572 |
| | Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity | Q69561833 |
| | Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage | Q69589550 |
| | Modification of experimental aminoglycoside nephrotoxicity | Q69681156 |
| | Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis | Q69921829 |
| | Once-daily dosing decreases renal accumulation of gentamicin and netilmicin | Q69936275 |
| | In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosa | Q69940703 |
| | Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers | Q70061551 |
| | Postantibiotic effects | Q70073524 |
| | In vivo postantibiotic effect in a thigh infection in neutropenic mice | Q70370760 |
| | Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic | Q70502539 |
| | Dissociation of maximum concentration of kanamycin in plasma and perilymph from ototoxic effect | Q70648323 |
| | Effect of sodium bicarbonate and ammonium chloride ingestion in experimental gentamicin nephrotoxicity in rats | Q71279354 |
| | Postantibiotic suppression of bacterial growth | Q71543981 |
| | Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro | Q71596714 |
| | Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice | Q71710583 |
| | Vancomycin enhancement of experimental tobramycin nephrotoxicity | Q28362084 |
| | Attenuation of experimental tobramycin nephrotoxicity by ticarcillin | Q28362582 |
| | Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs | Q30501061 |
| | Determinants of efficacy and toxicity of aminoglycosides | Q34510814 |
| | Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity | Q35258719 |
| | Early effects of beta-lactams on aminoglycoside uptake, bactericidal rates, and turbidimetrically measured growth inhibition in Pseudomonas aeruginosa | Q35535832 |
| | Aminoglycoside-induced hearing loss in humans | Q38676819 |
| | Use of antimicrobial agents in renal failure | Q38681646 |
| | Role of pharmacokinetics in the outcome of infections | Q39639407 |
| | What price success? The continuing saga of the toxic:therapeutic ratio in the use of aminoglycoside antibiotics | Q39652048 |
| | Mechanism of bactericidal action of aminoglycosides. | Q39675399 |
| | Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model | Q39833928 |
| | Postantibiotic effect of imipenem on Pseudomonas aeruginosa | Q39849241 |
| | Renal pharmacology of aminoglycoside antibiotics. | Q40202724 |
| | Dosage schedules of antimicrobial agents: a historical review. | Q40350770 |
| | One shot of high-dose amikacin: a working hypothesis | Q41193383 |
| | A study of amikacin given once versus twice daily in serious infections | Q41274203 |
| | Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats | Q41810184 |
| | The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess | Q42208982 |
| | Controlled Comparison of Gentamicin and Tobramycin Nephrotoxicity | Q42247293 |
| | Influence of dosage regimen on experimental tobramycin nephrotoxicity. A biochemical approach | Q42254296 |
| | Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole | Q42255800 |
| | Complete protection from gentamicin-induced acute renal failure in the diabetes mellitus rat. | Q42264310 |
| | Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone | Q43459102 |
| | Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model | Q43617611 |
| | A comparative trial of sisomicin therapy by intermittent versus continuous infusion | Q43703442 |
| | Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model | Q43932771 |
| | The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats | Q44092671 |
| | Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits | Q44382589 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure | Q45199122 |
| | Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia | Q46611376 |
| | Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin | Q46984010 |
| | The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. | Q52695343 |
| | Increasing dietary calcium moderates experimental gentamicin nephrotoxicity | Q57228063 |
| | Aminoglycoside Ototoxicity: Influence of Dosage Regimen on Drug Uptake and Correlation between Membrane Binding and some Clinical Features | Q58290011 |
| | Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis | Q67281381 |
| | Effect of Sodium Intake on Gentamicin Nephrotoxicity in the Rat | Q67446225 |
| | Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis | Q67931093 |
| | Interaction of aminoglycoside antibiotics and calcium channel blockers at the neuromuscular junctions | Q68024684 |
| | Clinical response and peak concentrations of aminoglycosides | Q68250382 |
| | Relation of dosing regimen to aminoglycoside ototoxicity: evaluation of auditory damage in the guinea pig | Q68715919 |
| | A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycin | Q68833375 |
| | The postantibiotic effect | Q69011396 |
| | Kinetics of antimicrobial activity | Q69494182 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 399-405 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Once-daily aminoglycoside therapy | |
| P478 | volume | 35 | |